Table 4 Management of patients admitted with acute cholecystitis during the COVID-19 pandemic, without distinction of RT-PCR swab test for COVID infection result
From: The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
Management | Count | % |
|---|---|---|
Endoscopic retrograde cholangiopancreatography (ERCP) ± sphincterotomy and delayed laparoscopic cholecystectomy | 183 | 6 |
Open intervention in urgent setting + antibiotics | 250 | 8 |
Conservative approach (antibiotics alone) and delayed laparoscopic cholecystectomy | 335 | 11 |
Laparoscopic intervention in urgent setting + antibiotics | 1474 | 51 |
Conservative approach (antibiotics alone) | 414 | 14 |
Interventional radiology/cholecystostomy/percutaneous drainage of gallbladder | 211 | 7 |
Conservative approach (antibiotics) + Cholecystectomy/ERCP + delayed laparoscopic cholecystectomy | 1 | 0 |
Conservative approach with antibiotic treatment-delayed intervention due to patient deterioration-percutaneous cholecystostomy | 1 | 0 |
2869 | 100 |